Bertoldo A, Pizzol D, Yon DK, et al
On the other end of the spectrum, the largest percentage increase affects a small group: the Panama Canal Benefit Plan (431), which is limited to employees working in the Panama Canal Zone
It is FDA-approved as Mounjaro for type 2 diabetes and Zepbound for chronic weight management
Tirzepatide is different because it is a GLP-1 receptor agonist and acts as a glucose-dependent insulinotropic polypeptide (GIP) receptor agonist
"Incorporate resistance-based workouts, weights, or bodyweight exercises like squats and push-ups, to help preserve strength and prevent muscle loss." You don't need a gym membership or expensive equipment
Available at: (Accessed: 27 February 2026) This equates to roughly 30 million people, and numbers are only rising